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Effector T lymphocytesAvian inﬂuenza virus (AIV) speciﬁc CD8+ T lymphocyte responses stimulated by intramuscular administration of
an adenovirus (Ad) vector expressing either HA or NPwere evaluated in chickens following ex vivo stimulation by
non-professional antigen presenting cells. The CD8+ T lymphocyte responses were AIV speciﬁc, MHC-I restricted,
and cross-reactedwith heterologousH7N2AIV strain. Speciﬁc effector responses, at 10 days post-inoculation (p.i.),
were undetectable at 2 weeks p.i., and memory responses were detected from 3 to 8 weeks p.i. Effector memory
responses, detected 1week following a booster inoculation, were signiﬁcantly greater than the primary responses
and, within 7 days, declined to undetectable levels. Inoculation of an Ad-vector expressing human NP resulted in
signiﬁcantly greaterMHC restricted, activation of CD8+ T cell responses speciﬁc for AIV. Decreases in all responses
with time were most dramatic with maximum activation of T cells as observed following effector and effector
memory responses.icine, Western University of
469 5635.
isson).
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Since 1996, the zoonotic threat of avian inﬂuenza viruses (AIV) has
beenexempliﬁed by the direct transmission of theH5N1 frompoultry to
humans in many countries throughout the world, including Asia, Africa
and Europe (Alexander, 2006; Capua and Alexander, 2002; Fauci, 2006;
Melidou, 2009). The AIV are classiﬁed as type A inﬂuenza viruses in the
Orthomyxoviridae family. Although shore birds and waterfowl, such as
ducks, swans, geese,waders and terns, are considered the original hosts,
AIV strains have also been isolated from pheasants, quails and poultry
(Alexander, 2006; Causey and Edwards, 2008; Collisson et al., 2008). In
poultry, the virulence of AIV determines its classiﬁcation as either low
pathogenic or highly pathogenic virus. Infection with low pathogenic
AIV strains produces asymptomatic to mild respiratory and enteric
disease, while infection with the highly pathogenic strains results in
clinical illness and systemic disease (Fauci, 2006; Krauss et al., 2007;
Olsen et al., 2006). Furthermore, poultry are considered a critical
intermediate host for adaptation of the AIV strains from wild birds tomammals, including swine and humans (Collisson et al., 2008; Perdue
and Swayne, 2005). Zoonotic infections of the H5N1 strains of AIV have
resulted in fatality in 60% of the cases reported, although human-to-
human transmission of the H5N1 is rare (Alexander, 2006). The
segmented nature of these negative strand RNA viruses facilitates
reassortment events that result in human strainswith gene segments of
avian origin (Capua and Alexander, 2002; Ungchusak et al., 2005;
Webster et al., 1992). The inﬂuenza pandemics of 1918, 1957 and 1968
were caused byhuman inﬂuenza viruses encoding genes of avian, swine
and human origins (Alexander, 2006; Capua and Alexander, 2002;
Causey and Edwards, 2008). The genome of the current “swine-like”
H1N1 of 2009 also carries two genes from AIV (Babakir-Mina et al.,
2009; Garten et al., 2009).
Both the zoonotic nature of AIV which provides a potential
mechanism for emergence of new human strains, and the economic
losses sustained by the poultry industry from AIV outbreaks justify
efforts to developmore efﬁcacious, safe vaccines (Capua and Alexander,
2002; Davison et al., 2003). While only inactivated, whole AIV and
fowlpox vectored vaccines are available commercially, AIV vaccines are
discouraged or prohibited in many countries, such as the United States
and many countries of the European Union (Capua and Marangon,
2003; Davison et al., 2003; Hall, 2004; Suarez et al., 2006). The use of
Fig. 1. Kinetics of the humoral immune response induced following i.m. inoculation
with Ad-HA. Serum HI antibody titers of individual chickens were evaluated, expressed
as log2 of the reciprocal of the greatest dilution of serum inhibiting agglutination of 1%
chicken RBCs by 4 HA units of the H5N9/Turkey/Wis/68 AIV. Results shown were
derived from two separate experiments.
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because of the inability to distinguish infected from vaccinated animals
(DIVA), and pre-existing immunity against fowlpox virus can prevent
the developmentof optimumprotective immunity against AIV (Davison
et al., 2003; Suarez et al., 2006; Swayne et al., 2000a,b). Incomplete
protection allows AIV strains to survive and circulate in ﬂocks and to
potentially mutate into highly pathogenic strains (Suarez et al., 2006;
Swayne et al., 2000b). The mass slaughter policy applied in the event of
highly pathogenic AIV outbreaks in poultry contributes to extensive
economic losses (Capua and Marangon, 2003; Davison et al., 2003).
Highly pathogenic strainswith an increase in infectious viral loadwithin
the bird are considered a risk to both birds and mammals.
In bothmice and chickens, the efﬁcacy of anon-replicating adenovirus
serotype5 (Ad5)basedvector, expressingHAof inﬂuenzavirus, toprotect
against a challengeofH5N1virushasbeendemonstrated (Gaoet al., 2006;
Hoelscher et al., 2007). Toro et al. (2007) have shown that in ovo
inoculation of the non-replicating (replication competent (RCA) free)
human adenovirus vectored vaccine encoding HA transgene of H5N9/
Tur/Wis/68AIV strain inducedneutralizing anti-HAantibody in chickens.
Although well-characterized, humoral immunity protects against the
viral strains expressing homologous HA protein by neutralization of the
virus, its efﬁcacy is limited against variant or heterologous viruses (Lee
et al., 2008; Rimmelzwaan et al., 2007; Seo and Collisson, 1997). The
ability of the non-replicating adenovirus vectored vaccine to induce
HA-speciﬁc CD8+ T lymphocyte responses in chickens has not been
determined.
The induction of CD8+ T lymphocyte immunity against infections of
respiratory viruses, such as inﬂuenza and infectious bronchitis viruses,
can greatly diminish the clinical disease by clearing virally infected cells
(Lee et al., 2008; Pei et al., 2003; Rimmelzwaan et al., 2007; Seo and
Collisson, 1997, 1998; Seo et al., 2002; Seo andWebster, 2001; Seo et al.,
2000; Tamura et al., 2005). Additionally, the CD8+ T lymphocytes target
more conserved epitopes than neutralizing antibodies and thus can
confer protection against a broader range of viruses with distinct
glycoproteins (Haghighi et al., 2009; Lee et al., 2008; Seo et al., 2002; Seo
and Webster, 2001; Swain et al., 2004). The studies in this manuscript
demonstrate that viral speciﬁc, MHC-I restricted effector and memory
CD8+ T lymphocytes are generated in chickens following administra-
tion of the RCA-free human Ad5 vector encoding AIV HA and to an even
greater extent, nucleocapsid protein (NP). Furthermore the T lympho-
cyte responses do cross-reactwith heterologousAIV and administration
of a booster dose induces amore robust secondary humoral and cellular
immune response against AIV.
Results
HA-speciﬁc, humoral immune responses following primary and booster
inoculation with a non-replicating adenovirus HA vector
Three-week-old chicks were given a primary inoculation i.m. with
1×108 ifu of the adenovirus vector expressing H5 protein of H5N9 (A/
Turkey/Wis/68) (Ad-HA) or with an equivalent amount of the empty
vector (AdE) (Toro et al., 2007). Eight weeks later, they were given
i.m. a secondary, booster inoculation. The HI titers of speciﬁc antibody
for the H5N9 AIV strain from chickens after primary inoculation with
theAd-HA vector ranged from4 to 8 log2 (GMT) (Fig. 1). Greater than a
16-fold increase in theHI titerswas observed 1 week post-boosting (p.
b.). No detectable HI activity was observed against a heterologous
H7N2 AIV strain. The sera from AdE and PBS inoculated chickens were
also negative for any HI activity (data not shown).
The Ad-HA vector induces AIV speciﬁc, effector, memory and effector
memory T lymphocyte responses
Speciﬁc T lymphocyte responses were also evaluated following the
i.m. inoculation of 3-week-old B19/B19MHC haplotype chickens withAd-HA or AdE vectors with 1×108 ifu. An indirect IFN-γ assay relying
on the production of NO by the HD-11 chicken macrophage cell line
was used to demonstrate AIV speciﬁc, ex vivo activation of T
lymphocytes by infected APCs. An effector T cell response to the HA,
detected at 10 days after administration of the Ad-HA, declined to
basal levels by 16 days p.i. Memory T lymphocyte responses were
detected by 3 weeks p.i. and maximum stimulation of viral speciﬁc T
lymphocytes derived fromAd-HA inoculated chickenswas detected at
5 weeks p.i. By 8 weeks p.i., T cell responses had declined to
undetectable levels.
Following the decline of memory responses of peripheral blood T
lymphocytes, 4 birdswere boostedwith a second, 1×108 ifu dose of Ad-
HAor AdE given i.m. at 8 weeks after the primary inoculation. At 1 week
p.b. with Ad-HA, the memory effector T cell responses detected
following ex vivo stimulation of T lymphocytes were signiﬁcantly
greater for theT cells isolated fromAd-HA inoculated chickens than for T
lymphocytes from AdE or PBS inoculated chickens. This secondary
effector response also markedly declined at 2 weeks p.b., similar to the
decline observed following the primary effector response.
Antigen speciﬁc activation of T lymphocytes from Ad-HA inocu-
lated chickens following culturing with AIV infected APCs was
demonstrated (Fig. 2A). Furthermore, the induction of the B19/B19
derived T lymphocytes by AIV infected B19/B19 APCs was MHC-I
restricted since B2/B2 infected CKC expressing MHC-I did not activate
these T lymphocytes (Fig. 2B). Lymphocytes from chickens inoculated
with empty AdE stimulated only basal levels of NO.
Direct IFNγ ELISA conﬁrmed the generation of HA-speciﬁc T lymphocyte
responses
In addition to the NO production a commercial ELISA kit (Invitrogen,
La Jolla, CA) directly evaluating the IFNγ production by activated T
lymphocytes conﬁrmed the AIV speciﬁc response of T lymphocytes at
10 days and 5 weeks p.i. and 1 week p.b (9 weeks p.i.) from chickens
receiving Ad-HA, with no response from those given AdE or PBS. The
mean amount of IFNγ produced by the primary effector T lymphocytes
at 10 days p.i. from Ad-HA inoculated chickens was 49.5 pg/ml which
was nearly 24-fold greater than that secreted from lymphocytes of
chickens inoculated with AdE (Fig. 3). The memory T lymphocytes
collected from chickens, 5 weeks p.i. with the HA adenovirus vector
secreted an average of 44 pg/ml of IFNγ which was more than 20-fold
greater than that produced by the T lymphocytes derived from chickens
Fig. 2. Kinetics of the AIV speciﬁc T lymphocyte responses from B19/B19, MHC
haplotype chickens following primary and booster inoculations with 1×108 ifu of RCA-
free human Ad5 adenovirus vector expressing AIV HA (Ad-HA). T lymphocytes isolated
from birds inoculated with Ad-HAwere ex vivo stimulatedwith H5N9 AIV infectedMHC
matched B19/B19 APCs before evaluating induction of the T lymphocyte response.
Activation was quantiﬁed as IFNγ secretion from T cells determined through
production of NO by an HD11 macrophage cell line. Results are expressed as the
average (±S.E.) of two experiments (n=6 or 7 birds). Each ex vivo stimulation assay is
denoted by the adenovirus vector inoculated animal source of T lymphocytes and virus
infected MHC-I APCs. (A) The APCs were kidney cells derived from B19/B19 chicks.
(B) The APCs were derived from mismatched B2/B2 chicks. The difference in the
responses of T lymphocytes from Ad-HA inoculated birds and AdE inoculated control
birds at 10 days and at 3 and 5 weeks p.i. were signiﬁcant (p≤0.001).
Fig. 3. An IFNγ ELISA conﬁrmed induction of speciﬁc T lymphocyte responses by
primary and booster administration of Ad-HA. Concentration of IFNγ secreted in the
supernatant of ex vivo APC-stimulated T lymphocytes was determined using a
commercial ELISA (Invitrogen, La Jolla, CA). Results are expressed as the average
(± S.E.) of 3 birds. Each ex vivo stimulation assay, using AIV infected B19/B19 derived
APCs, is denoted by the adenovirus vector inoculated animal source of T lymphocyte
and virus infected MHC-I APCs. Uninfected APCs did not elicit a response. The difference
between IFNγ secretion by activation of T lymphocytes derived from Ad-HA and AdE
inoculated chickens was signiﬁcant (p≤0.001).
Fig. 4. T lymphocytes from Ad-HA inoculated chickens responsible for the AIV speciﬁc,
MHC restricted responses were CD8+. At 6 weeks p.i., the T lymphocytes from the
peripheral blood mononuclear cells were separated into CD4+ and CD8+ subpopula-
tions prior to stimulation with AIV infected and uninfected B19 APCs. The activation of
the T lymphocytes was measured by indirect stimulation of NO production. Results are
expressed as average NO production (±S.E) of an n of 3 birds.
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were alsoMHC restricted responses at 10 days, aswell as 5 weeks p.i. At
5 weeks p.i., IFNγ secreted by the B19/B19 infected APC-stimulated T
lymphocytes from Ad-HA inoculated birds was more than 44-fold
greater than the IFNγ secreted by the lymphocytes stimulated by
mismatched B2/B2 infected APCs (data not shown). The IFNγ
production from the memory effector cells as detected by the ELISA
1 week p.b. also conﬁrmed greater AIV speciﬁc and MHC-I restricted
secondary effector responses. The results obtained by ELISA were in
corroboration with the results from NO production assay for CD8+ T
lymphocyte responses at 10 days and 5 weeks p.i. and 1 week p.b.
AIV speciﬁc memory T lymphocytes are mostly CD8+
To determine the phenotype of the responding memory T
lymphocytes reacting to AIV infected APCs, T lymphocyte subpopula-
tions expressing either CD8 or CD4 were enriched by negative
selection using speciﬁc antibody and magnetic beads (28) prior to ex
vivo stimulation with the B19/B19 (MHC matched) haplotype APCs.
Either CD4+ or CD8+ cells were enriched from T lymphocytes
prepared from PBMC collected at 6 weeks p.i. The T lymphocytesenriched for the CD8+ phenotype were primarily responsible for the
AIV speciﬁc, MHC restricted T cell responses (Fig. 4). The marginal
stimulation of CD4+ lymphocytes from chickens given the AdE
without HA by AIV infected APCs was not reproducible in repeated
experiments.
H5 speciﬁc, CD8+ T lymphocytes were activated by heterologous H7
infected APCs
The potential for T lymphocytes from H5 Ad-HA to cross-react with
H7 was determined at 7 weeks p.i., when the responses remained
detectable. Using H7N2 infected APCs for ex vivo stimulation of T
lymphocytes, activation was detected by secretion of IFNγ using the
macrophage secretion of NO and the ELISA (Invitrogen, La Jolla, CA). The
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different whether the APCs were infected with the H5 or the H7 virus,
although the response to H5 virus infected APCs was slightly greater
(Fig. 5). Using either the indirect NOproduction assay (Fig. 5A) or direct
ELISA (Fig. 5B) to detect T cell secretion of IFNγ, the responses of CD8+ T
lymphocytes to APCs infected with homologous H5 virus were 10 fold
greater than responses of CD4+ lymphocytes. Responses of CD8+ T cells
to APCs infected with heterologous H7 virus were 7 fold greater than
responses of CD4+ lymphocytes (p≤0.001–0.0001). Stimulation of
either CD8+ or CD4+ T lymphocyte populations from AdE or PBS
inoculated chickens was either very weak or absent.
AIV speciﬁcmemory responsesweredetected in spleenderivedT lymphocytes
Memory T lymphocyte subpopulations in the spleens were
evaluated 4 weeks p.b., when the study was terminated. Whole T
lymphocyte populations and the puriﬁed CD4+ and CD8+ T
lymphocyte subpopulations were stimulated ex vivowith AIV infected
and uninfected B19/B19 APCs. The stimulation of the T lymphocytes
from the spleens of the Ad-HA inoculated chickens was AIV speciﬁcFig. 5. CD8+ T lymphocytes from B19 birds inoculated with Ad-HA respond to APCs
infected with the homologous (H5N9) or a heterologous (H7N2) virus. At 7 weeks p.i.,
puriﬁed CD4+ and CD8+ T lymphocytes from chickens (n=3) inoculated with Ad-HA
were stimulated by B19 derived APCs infected with either the H5N9 or H7N2 strain.
Assays represent the mean (± S.E.) of T lymphocytes of 3 birds; (A) The T lymphocyte
responses as determined by the indirect IFNγ assay, and (B) The T lymphocyte
responses of the same birds as determined by the direct IFNγ ELISA. Responses of CD8+
T lymphocytes were signiﬁcantly greater than those of the CD4+ T lymphocytes
(p≤0.01 and p≤0.001, respectively, as determined by the two assays).and MHC-I restricted. The secondary splenic T lymphocyte response,
which was lower in comparison to the peripheral lymphocyte
secondary effector response at 7 weeks, was mediated primarily by
CD8+ lymphocytes (Fig. 6). In contrast, the activation of the CD4+ T
lymphocytes was 7 fold lower (p≤0.003) and non-speciﬁc as
indicated by stimulation with uninfected APCs.
Non-replicating adenovirus NP expression vector stimulated greater T
lymphocyte responses than the HA vector
Studies using plasmid expression vectors indicated that in chickens
the CD8+ T lymphocyte response directed against AIV NP may bemore
vigorous than that against HA (Singh et al., 2010). Therefore, the T
lymphocyte responses following inoculation of theRCA-freeAd5human
adenovirus vector expressing NP (Ad-NP) were compared with the Ad-
HA (Fig. 7). Although the origin of the NP was a human H1N1/PR8
(GenBank accession EF190983.1), the NP protein has 93% amino acid
identity with the H5N9 AIV NP. Six 3-week-old B19 haplotype chickens
were inoculated with 1×108 ifu of Ad-NP or Ad-HA. The AIV speciﬁc
responses of T lymphocytes prepared from PBMCs collected at 10 days,
5 weeks and 7 weeks p.i. were evaluated by ex vivo activation using
H5N9 infected APCs or the uninfected APCs. The activation of
lymphocytes was determined with the direct ELISA. The 10 day p.i.
effector and 5 week p.i. memory responses of T lymphocytes collected
from the Ad-NP inoculated chickens were greater than those from HA
inoculated chickens (p≤0.02 and p≤0.09, respectively). Moreover, the
T lymphocytes collected from Ad-NP inoculated chickens also were
induced by heterologous virus, H5N9/Turkey/Wis/68 infected APCs. At
7 weeks p.i., the separation of T lymphocytes into CD4+ and CD8+
subpopulations indicated a 48-fold greater activation of CD8+ T
lymphocytes compared to CD4+ T lymphocytes. The responses of T
lymphocytes speciﬁc for either NP or HA declined by 7 weeks. The
decline in the NPwas far greater than the decline of the response to HA
narrowing the difference between responses to NP and HA. However,
the NP appeared to remain a signiﬁcantly (p≤0.006) better CD8+ T cell
antigen than HA even at 7 weeks p.i.
Discussion
The increased incidence of outbreaks of highly pathogenic AIV
infections in poultry throughout the world and the threat of emergenceFig. 6. AIV speciﬁc CD8+ T lymphocytes were detected from spleens of Ad-HA inoculated
chickens 4 weeks p.b. Unseparated or the antibody enriched CD4+ and CD8+ splenic T
lymphocytes isolated from chickens inoculatedwith adenovirus vectorwere stimulated ex
vivowithMHCmatched B19/B19 APCs infectedwith homologous H5N9 virus. Production
of NO by macrophages induced by secretion of IFNγ from stimulated T lymphocytes was
used to quantify the activation of the lymphocytes. Results are expressed as the average
(± S.E.) of 4 birds. Each ex vivo stimulation assay is denoted by the adenovirus vector
inoculated animal source of T lymphocyte and virus infected MHC-I APCs. AIV speciﬁc
memory CD8+ T lymphocyte responses in the spleens were signiﬁcantly greater than the
CD4+ T lymphocyte responses (p≤0.003), but not signiﬁcantly different from the
response of the unseparated lymphocytes.
Fig. 7. CD8+ lymphocyte responses of birds receiving the Ad-NP vector were greater
than those from birds receiving the Ad-HA vector. T lymphocytes, prepared from B19/
B19 chickens inoculated with either vector (n=3), were ex vivo stimulated with H5N9
AIV infected B19 APCs. The responses of the T lymphocytes were determined using an
IFNγ ELISA. Results are expressed as the average (± S.E.) of 3 birds. Each ex vivo
stimulation assay is denoted by the adenovirus vector inoculated animal source of T
lymphocytes and virus infected MHC-I APCs.
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more efﬁcacious vaccines for these viruses (Capua andMarangon, 2003;
Collisson et al., 2008; Fauci, 2006; Swayne and Kapczynski, 2008).
Although humoral immunity provides protection against a speciﬁc AIV
HA type or subtype, protection against serologically distinct HA variants
is limited (Lee et al., 2008; Rimmelzwaan et al., 2007). In contrast, the
immune responses mediated by CD8+ T lymphocytes have broad
application for antigenically distinct strains (Haghighi et al., 2009; Lee
et al., 2008; Seo et al., 2002; Seo and Webster, 2001). In the current
study, avian CD8+ T lymphocyte responses to AIV were identiﬁed
following the inoculation of RCA-free Ad5 vectors expressing AIV HA or
inﬂuenza virus NP. Our studies demonstrated that T lymphocytes
induced by RCA-free Ad5 vectors expressing either the HA or NP were
speciﬁc for both the autologous AIVH5N9 and a heterologous H7N2 AIV
strain. The twoHAproteins share only 41%amino acid sequence identity
while the NP expressed by this vector shares 93% identitywith the NP of
theH5N9 virus used to infect the APCs. The vigorousAIV speciﬁc CD8+T
lymphocyte responses induced by the RCA-free human Ad5 vectors
expressing either the HA or the NP were AIV speciﬁc and MHC-I
restricted. TheAd-HA studies further provide theﬁrst quantiﬁcation of a
viral speciﬁc secondary or booster T cell response in chickens.
The capacity of adenovirus vectored vaccines expressing inﬂuenza
viral proteins to stimulate CD8+ T lymphocytes has been demonstrated
inmice (Hoelscher et al., 2007; Holman et al., 2008; Singh et al., 2008). A
replication competent (an E1/E3 deleted) adenovirus vectored AIV
vaccine was shown to protect chickens from challenge with homolo-
gous virus (Gaoet al., 2006). Toro et al. (2007) showed that theRCA-free
human Ad5 vector expressing H5N9 AIV HA used in this current study
protected chickens against highly pathogenic AIV H5N1 and H5N2
variants. Although inoculation of chickens with these Ad-HA vectored
adenoviruses resulted in production of anti-HA antibodies and HI of
homologous virus, antibody responses in our study failed to inhibit
hemagglutination mediated by the heterologous, H7N2, AIV strain. In
addition, the activation of CD4+ T lymphocytes from Ad-HA inoculated
chickens following stimulation with both AIV infected and uninfected
APCs could not be consistently demonstrated, for example at week 7
post-primary inoculation and at week 4 post-booster inoculation with
theAd-HA. The lack of CD4+T lymphocyte response can be attributed to
the absence of MHC-II expression on the surface of APCs.With comprehensive time course studies, the persistent control of
each T cell response can be appreciated. Declines were observed
following the effector, memory and memory effector responses. The
current studies further established the transient nature of the
responding AIV speciﬁc, CD8+ T lymphocytes following primary and
booster administration of Ad-HA. Similar to the MHC-I restricted, T
lymphocyte responses stimulated by infection with whole IBV or AIV
or inoculation with recombinant fowlpox vector expressing AIV HA,
the primary effector CD8+ T lymphocyte response was observed at
10 days p.i. (Haghighi et al., 2009; Seo et al., 2000, 2002). However at
16 days p.i., the responses of the T lymphocytes to IBV or the Ad-HA
were undetectable. The AIV speciﬁc memory T lymphocyte response
induced by Ad-HA could be observed between 3 weeks and 7 weeks
p.i. Although the magnitude of the memory response was greatest
at 5 weeks p.i., it remained lower than the primary effector
response observed at 10 days p.i. or the booster effector response.
The response of the memory T lymphocytes declined by 7 weeks
after the primary inoculation of the vector and was reduced to
nearly undetectable levels at 8 weeks p.i. Seo and Webster observed
that in chickens inoculated with H9N2 AIV, the protection against a
challenge with a variant virus had greatly declined by 10 weeks p.i.
(Seo and Webster, 2001; Seo et al., 2002). Similarly, a decline in the
human memory T lymphocyte responses has been reported with
time (McMichael et al., 1983). The mechanism for this apparent
regulation of CD8+ T lymphocyte activity is not know although
increased apoptosis was associated with the decrease in the
response to IBV following the effector response (Pei et al., 2003).
The impact of booster, secondary inoculation of the vectors on the
chicken T lymphocyte mediated responses was also determined in the
current studies. Induction of mice and non-human primate immune
responses to adenovirus vaccine vectors following primary inocula-
tion have been shown to be an impediment to their efﬁcacy for further
homologous challenge with the same vector (Liu et al., 2008;
Schirmbeck et al., 2008; Tatsis et al., 2009). However, in contrast,
the induction of a robust chicken T lymphocyte response with a 16-
fold increase in anti-HA antibody titers 1 week post-boosting with the
same Ad-HA vector, demonstrates the efﬁcacy for challenge infection.
Toro et al. (2008) have also established that in ovo vaccination of
chickenswith H5 Ad vectored vaccine did not impair the development
of protective immunity induced by the post-hatched vaccination with
the same Ad-vector expressing different HA. The presence of pre-
existing immunity against the Ad-vector and HA did not inhibit the
efﬁcacy of this vaccine to stimulate a secondary cellular immune
response against HA in chickens. This could be attributed to the non-
replicating nature of the vector, establishing a weaker immune
response against the adenovirus vector itself (Toro et al., 2008).
Additionally, the present study established that the non-replicat-
ing Ad-vector encoding an NP originating from a human H1N1/PR8
inﬂuenza virus has the ability to induce chicken T lymphocyte
mediated responses that can cross-react with an AIV derived NP.
Studies with mice have also demonstrated the immunodominance of
NP in induction of CD8+ T lymphocytes (Lee et al., 2008; Vitiello et al.,
1996; Yewdell et al., 1985). Our previous studies using plasmid DNA
expressing HA or NP further indicated that the NP induced a greater,
MHC-I restricted CD8+ T lymphocyte response than HA in chickens
(Singh et al., 2010). The presence of memory T lymphocytes in the
peripheral blood speciﬁc for both viral proteins is detectable only for
7 weeks p.i. of the primary inoculation. The presence of responding
memory T lymphocytes in the spleens 4 weeks p.b. indicated that
circulating memory lymphocytes also localize to central immune
organs in chickens. IBV speciﬁc, MHC restricted, splenic T cells from
chickens were also identiﬁed following primary infection (Pei et al.,
2003; Seo and Collisson, 1998; Seo et al., 2000).
This study conclusively demonstrates that RCA-free Ad5 human
adenovirus vectored vaccine expressing HA has the potential to
induce both cell mediated and humoral immunity against AIV HA in
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Ad5 vector has the ability to effectively cross-react with heterologous
AIV strains. Additionally, this study distinctly establishes that booster
or secondary administration of an HA expressing human adenoviral
vector stimulates an efﬁcacious secondary CD8+ T lymphocyte
response in chickens. Therefore, the RCA-free Ad-HA vector may
also be applicable in an avian homologous prime-boost vaccination
program.
Materials and methods
Viruses
Viral stocks of low pathogenic AIVs, H5N9 (A/Turkey/Wis/68)
and H7N2 (A/Turkey/Virginia/158512/02), were propagated in the
allantoic sacs of 10-day-old, embryonated chicken eggs (ECE) for
48 h and virus was identiﬁed by the hemagglutination HA assay
performed according to OIE guidelines (http://www.oie.int/eng/
normes/mmanual/2008/pdf/2.03.04_AI.pdf). Virus titers were de-
termined in embryonated eggs and expressed as embryo infectious
doses 50% (EID50) (Beard, 1989).
Vector
An RCA-free E1/E3 deleted human adenovirus serotype 5 (Ad5)
vector encoding HA gene from H5N9 (A/Turkey/Wis/68) AIV, (Ad-
HA) was synthesized as described previously (Toro et al., 2007). The
NP fragment used to generate the adenovirus NP vector (Ad-NP) was
ampliﬁed by PCR fromH1N1/PR8 NP-encoding plasmid pVIJ-NP using
a primer pair creating unique EcoRI sites at both ends of the NP
fragments. The PCR-ampliﬁed NP product was subsequently cloned
into the EcoRI site of shuttle plasmid pAC-SR to create the plasmid
pAC-NP. The adenovirus Ad-NP was generated by co-transfecting
pAC-NP and Ad5 backbone plasmid pJM17 in human 293 cells as
described previously by Shi et al. (2001). The seed Ad-NP vector stock
was plaque selected and validated by PCR analysis. Virus titers were
determined by the Adeno-X rapid titer kit (BD Clontech, Mountain
View, CA), according to the manufacturer's protocol, and expressed as
infectious units (ifu) perml. The amino acids of the NP fromH1N1 and
NP from H5N9 AIV were 93% identical.
Experimental animals
Embryonated eggs of B19/B19 MHC-deﬁned chicken lines were
obtained from Dr. Briles’ laboratory at Northern Illinois University
(DeKalb, IL). Post-hatching, the chicks were housed in a speciﬁc,
pathogen free environment at the vivarium facility of Western
University of Health Sciences, Pomona, CA. All procedures involving
the use of chickens were approved by and conducted according to
guidelines established by the Institutional Animal Care and Use
Committee ofWestern University of Health Sciences. At 3 and 9weeks
of age, chickens with the B19/B19 MHC haplotype were inoculated
intramuscularly (i.m.) with 0.3 ml (1×108 ifu total) of Ad-HA or Ad-
NP vectors. Control birds were inoculated with either AdE, the empty
vector without AIV genes, or PBS only.
Determination of HA-speciﬁc antibodies
Serum samples were prepared from blood collected from the
jugular vein of chickens at various times post-inoculation (p.i.) to
evaluate the humoral responses. The hemagglutination inhibition (HI)
assay was used to determine titers of anti-HA antibodies speciﬁc to
H5N9 virus (A/Turkey/Wis/68) HA and H7N2 (A/Turkey/Virginia/
158512/02) and expressed as geometric mean titers (GMT) (http://
www.oie.int/eng/normes/mmanual/2008/pdf/2.03.04_AI.pdf).Generation of antigen presenting cells (APCs)
Primary chicken kidney cell (CKC) lines were established from 10-
day-old chicks of B19/B19 and B2/B2 MHC haplotypes as described
previously (Seo and Collisson, 1997). Cells from the tenth passage
were used as non-professional antigen presenting cells (APCs) for the
stimulation of CD8+ T lymphocytes. Flow cytometric analysis of CKCs
labeled with mouse anti-chicken MHC-I and MHC-II monoclonal
antibodies (Mab) indicated that these CKCs expressed surface MHC-I
but not detectable MHC-II (data not shown).
T lymphocyte preparation
Peripheral blood mononuclear cells (PBMC) or splenocytes of the
inoculated birds were the source of ex vivo stimulated effector T
lymphocytes (Seo and Collisson, 1997). Brieﬂy, blood was collected
from the jugular vein of chicks, and mononuclear cells were prepared
by Ficoll-histopaque (Histopaque-1077, Sigma-Aldrich, St. Louis, MO)
density gradient centrifugation (Seo et al., 2002). Viable mononuclear
cells were collected from the interface and washed twice with
phosphate buffered saline (PBS, pH 7.4). Cells were resuspended in
3 ml of RPMI 1640 (Invitrogen, La Jolla, CA) supplemented with 10%
fetal bovine serum (Gemini Bio-Products, West Sacramento, CA),
2 mM L-glutamine, and 0.1 mM MEM non-essential amino acids. B
lymphocytes were removed by passing the cell suspension through
nylon wool columns equilibrated with complete RPMI and adherent
cells were removed by incubating the cell preparation in 25 cm2 tissue
culture ﬂasks as described previously (Seo and Collisson, 1997). The
recovered T lymphocytes were 97% positive for the expression of CD3
on their surface as determined by ﬂow cytometric analysis (Beckman
Coulter Cytomics FC 500 Flow Cytometer, Brea, CA) of the cells labeled
with ﬂuorescent tagged mouse anti-chicken CD3 Mabs (Southern
Biotech, Birmingham, AL).
Separation of CD8+ and CD4+ T lymphocytes
The CD8+ and CD4+ T lymphocytes were separated by antibody-
mediated depletion using Dynabeads (Invitrogen, La Jolla, CA). The
puriﬁed T lymphocytes were labeled with either mouse anti-chicken
CD8 or mouse anti-chicken CD4 monoclonal antibodies (Mab)
(Southern Biotech, Birmingham, AL) at a concentration of 1 µg/106
cells in PBS containing 0.1% bovine serum albumin fraction V (Sigma-
Aldrich, St. Louis, MO) and incubated at 4 °C for 30 min. The
unattached antibodies were removed by two washes with PBS and
the cells were incubated with rat anti-mouse IgG coated Dynabeads,
DynaMag-2 (Invitrogen, La Jolla, CA) according to the manufacturer's
protocol, and the unlabeled cells in the supernatants were collected.
The purity of the T lymphocyte subpopulations was conﬁrmed by
FACS analysis on cells labeled with ﬂuorescent tagged, anti-chicken
CD4 or CD8 Mabs (Bohls et al., 2006). The T lymphocyte subpopula-
tions recovered after antibody mediated depletion were 95% pure for
the expression of either CD4 or CD8 on the surface of the cells.
Ex vivo stimulation of T lymphocytes
T lymphocytes prepared from PBMC or spleens were stimulated ex
vivo with MHC B19/B19 (matched) and B2/B2 (mismatched) APCs
(Briles and Briles, 1987). APCs at a density of 1×105 cells/ml were
incubated for 8 h at 39 °C, 5% CO2 in 96-well tissue culture plates. Each
well of APCs was infected with 1×105 ELD50 of the H5N9 virus for 1
h followed by removal of the unattached virus by three washes with
DMEM supplemented with 10% FBS. T lymphocytes (1×106) in
complete RPMI were added 4 h after infection of the APCs. The APCs
and T lymphocytes were co-cultured for 24 h at 39 °C, 5% CO2 before
the media was collected and the supernatant clariﬁed by centrifuga-
tion. Each ex vivo stimulation assay was conducted in duplicate.
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Activation of T lymphocytes was evaluated by either indirectly or
directly determining the concentration of IFNγ in the clariﬁed
supernatants from T lymphocyte cultured with APCs. Indirect
concentrations were determined using a nitric oxide detection assay
following incubation with a chicken macrophage line and the direct
concentrations were determined using a commercial ELISA (Invitro-
gen, La Jolla, CA) (Ariaans et al., 2008; Lambrecht et al., 2004). Each ex
vivo stimulation assay was conducted in duplicate.
Nitric oxide secretion by IFNγ stimulated HD11 cells, a chicken
macrophage cell line, was evaluated using a modiﬁcation of the assays
described by Karaca et al. (1996), Crippen et al. (2003) and Pei et al.
(2003). Cells were incubated in individual wells of 96-well plates at a
density of 105 cells/well in complete RPMI for 2 h at 39 °C, 5% CO2,
prior to the addition of 100 µl of supernatants from T lymphocyte-APC
cultures. After 24 h of incubation, the accumulation of nitrite from
stimulated HD11 cells was measured using the Griess reagent assay
according to the manufacturer's protocol (Sigma-Aldrich, St. Louis,
MO). The concentration of nitrite produced was determined using
sodium nitrite solutions with concentrations of 1–20 µmoles as
standards. The concentration of any non-speciﬁc production of nitric
oxide by soluble factors was removed by subtracting the nitrite
concentration of supernatants from APCs cultured without T lympho-
cytes from the supernatants of the APCs cultured with T lymphocytes.
Statistical signiﬁcance of differences
The nitric oxide and the ChIFN-γ concentrations were expressed as
averages of three to four birds per group. ANOVA (analysis of variance)
with signiﬁcance of pb0.05 was used to determine statistical
differences.
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